Latest news
Aurinia Pharmaceuticals Inc. 2026: Revenue $83.22M, EPS $0.28— 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 12:21:02 GMTAUPH: Strong revenue and profit growth fueled by LUPKYNIS sales and disciplined capital allocation - TradingViewTradingView · Thu, 06 Aug 2026 12:19:11 GMTAurinia Pharmaceuticals posts Q2 revenue $83.2M, net income $37.4M; reiterates 2026 guidance - TradingViewTradingView · Thu, 06 Aug 2026 12:13:01 GMTAUPH: Strong revenue and net income growth driven by LUPKYNIS, with robust 2026 outlook - TradingViewTradingView · Thu, 06 Aug 2026 12:06:38 GMTBRIEF-Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million - TradingViewTradingView · Thu, 06 Aug 2026 12:01:01 GMTAurinia Pharmaceuticals Inc Revenue Breakdown – NASDAQ:AUPH - TradingViewTradingView · Sat, 01 Aug 2026 06:09:33 GMTAUPH Q2'26 Earnings: EPS estimate is 0.24 USD - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMT